Heartbeam Inc (BEAT)

Currency in USD
1.480
+0.080(+5.71%)
Closed·
1.490+0.010(+0.68%)
·
BEAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3651.485
52 wk Range
0.5404.000
Key Statistics
Prev. Close
1.4
Open
1.39
Day's Range
1.365-1.485
52 wk Range
0.54-4
Volume
429.01K
Average Volume (3m)
11.35M
1-Year Change
-27.0936%
Book Value / Share
0.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BEAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.375
Upside
+263.18%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Heartbeam Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

Heartbeam Inc Earnings Call Summary for Q3/2025

  • HeartBeam reported Q3 2025 net loss of $5.3M with EPS of -$0.15, missing forecasts by 87.5%, causing shares to drop 5.99% and an additional 1.44% in aftermarket trading.
  • The company's cash position stands at $1.9M with operating cash burn of $3.2M, an 8% decrease quarter-over-quarter, raising concerns about financial sustainability.
  • HeartBeam anticipates FDA clearance for its 12-lead ECG synthesis by year-end, with commercial launch planned for early 2026 and modest growth projected for H1 2026.
  • CEO Rob Eno emphasized the 'transformative potential' of HeartBeam's cardiac care technology as the company transitions to a commercial entity for the first time in 2026.
  • Despite securing initial FDA clearance and having a robust patent portfolio, the company faces challenges with financial stability, market acceptance, and limited cash reserves.
Last Updated: 13/11/2025, 22:28
Read Full Transcript

Compare BEAT to Peers and Sector

Metrics to compare
BEAT
Peers
Sector
Relationship
P/E Ratio
−2.9x−2.2x−0.5x
PEG Ratio
−0.56−0.090.00
Price/Book
146.2x14.2x2.6x
Price / LTM Sales
-3.7x3.2x
Upside (Analyst Target)
220.9%72.0%51.4%
Fair Value Upside
Unlock14.1%7.1%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.375
(+263.18% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Benchmark
Buy8.00+440.54%-Upgrade11/12/2025
H.C. Wainwright
Buy5.50+271.62%2.50Maintain11/12/2025
H.C. Wainwright
Buy2.50+68.92%-New Coverage08/12/2025
Roth/MKM
Buy4.00+170.27%-New Coverage31/10/2025
Benchmark
Buy8.00+440.54%-Maintain29/08/2025

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.15 / -0.08
Revenue / Forecast
-- / 2.63M
EPS Revisions
Last 90 days

People Also Watch

1.4400
JZXN
-5.88%
5.15
ACVA
+0.59%
0.05
ELPW
0.00%
1.4500
TRNR
-8.23%

FAQ

What Is the Heartbeam (BEAT) Share Price Today?

The Heartbeam stock price today is 1.480 USD.

What Stock Exchange Does Heartbeam (BEAT) Trade On?

Heartbeam is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Heartbeam?

The stock symbol (also called a 'ticker') for Heartbeam is "BEAT."

What Is the Current Heartbeam Market Cap?

As of today, Heartbeam market cap is 59.370M USD.

What Is Heartbeam's (BEAT) Earnings Per Share (TTM)?

The Heartbeam EPS is currently -0.657 (Trailing Twelve Months).

When Is the Next Heartbeam Earnings Date?

Heartbeam's next earnings report will be released on 12/03/2026.

Is BEAT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Heartbeam moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Heartbeam Stock Split?

Heartbeam has split 0 times. (See the BEAT stock split history page for full effective split date and price information.)

How Many Employees Does Heartbeam Have?

Heartbeam has 16 employees.

What is the current trading status of Heartbeam (BEAT)?

As of 10/03/2026, Heartbeam (BEAT) is trading at a price of 1.480 USD, with a previous close of 1.400 USD. The stock has fluctuated within a day range of 1.365 USD to 1.485 USD, while its 52-week range spans from 0.540 USD to 4.000 USD.

What Is Heartbeam (BEAT) Price Target According to Analysts?

The average 12-month price target for Heartbeam is 5.375 USD, with a high estimate of 8 USD and a low estimate of 4 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +263.18% Upside potential.

What Is the BEAT Premarket Price?

BEAT's last pre-market stock price is 1.390 USD. The pre-market share volume is 35,840.000, and the stock has decreased by -0.010, or -0.710%.

What Is the BEAT After Hours Price?

BEAT's last after hours stock price is 1.490 USD, the stock has decreased by 0.010, or 0.680%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.